Organogenesis Holdings Inc. ORGO

Updated: 9 Aug 2026

NASDAQ | Biotech | Regenerative medicine and wound care

No signal published yet

We already track Organogenesis Holdings and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow Organogenesis Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Regenerative medicine and wound care
We're already tracking Organogenesis Holdings Inc. — here are the latest events we've registered

Recent News

  • On August 6, 2026, Organogenesis reported its second-quarter 2026 financial results, recording net product revenue of $42.8 million. The company reported sequential volume growth in its wound care business despite year-over-year revenue declines driven by Medicare reimbursement policy changes. Additionally, Organogenesis highlighted FDA acceptance of its Biologics License Application for Amnuvx to treat knee osteoarthritis, with a target action date of April 24, 2027.

What Firelda Watch includes for Organogenesis Holdings Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of Organogenesis Holdings Inc. will be delivered in the same format.

Want to follow Organogenesis Holdings Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow Organogenesis Holdings free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Organogenesis Holdings Inc. ORGO
Organogenesis Holdings — follow and we'll monitor it
Follow Organogenesis Holdings free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.